SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-017473
Filing Date
2017-06-28
Accepted
2017-06-28 19:52:26
Documents
2
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7781
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4660
  Complete submission text file 0000899243-17-017473.txt   13789
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AILERON THERAPEUTICS INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Yanchik Joseph A., III (Reporting) CIK: 0001618154 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 17936547